Skip to main content
SpringerLink
Log in

Efficacy and safety of treatment with interferon-α2b plus ribavirin in children with chronic hepatitis C

  • Practice Point
  • Published:

From Nature Clinical Practice Gastroenterology & Hepatology

View current issue Sign up to alerts

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Wirth S et al. (2002) Recombinant alfa-interferon plus ribavirin therapy in children and adolescents with chronic hepatitis C. Hepatology 36: 1280–1284

    Article  CAS  Google Scholar 

  2. Kowala-Piaskowska A et al. (2005) Factors influencing early virological response in children with chronic viral hepatitis C treated with pegylated interferon and ribavirin. Hepatol Res 32: 224–226

    CAS  PubMed  Google Scholar 

  3. Manns MP et al. (2001) Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomized trial. Lancet 358: 958–9654

    Article  CAS  Google Scholar 

  4. Mozer-Lisewska I et al. (2003) Virus genotype 1b and long-term response to interferon alpha monotherapy in children with chronic hepatitis C. Eur J Pediatr 162: 755–759

    Article  CAS  Google Scholar 

  5. Bruno S et al. (2004) Peginterferon alfa-2b plus ribavirin for naive patients with genotype 1 chronic hepatitis C: a randomized controlled trial. J Hepatol 41: 474–481

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Rachel Jones, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. Deputy Head of the Department of Infectious Diseases and Child Neurology at the University of Medical Sciences, Poznań, Poland

    Iwona Mozer-Lisewska

Authors
  1. Iwona Mozer-Lisewska
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Iwona Mozer-Lisewska.

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mozer-Lisewska, I. Efficacy and safety of treatment with interferon-α2b plus ribavirin in children with chronic hepatitis C. Nat Rev Gastroenterol Hepatol 3, 316–317 (2006). https://doi.org/10.1038/ncpgasthep0495

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpgasthep0495

  • Springer Nature Limited

Search

Navigation